Tryp Therapeutics And Massachusetts General Hospital To Conduct Phase 2 Psilocybin Study On IBS Jan 4, 2023
Cowen “Not At All Constructive” About Federal Cannabis Reform Chances In The New Congress Jan 4, 2023
Numinus CEO Payton Nyquvest Answers Investor Questions And Gives Look-Ahead Outlook For 2023 Dec 30, 2022
Psilocybin Therapy For Autism-Like Disorder Receives Approval For Phase 2a Clinical Trial Dec 28, 2022
